Health Canada
Symbol of the Government of Canada
Drugs and Health Products

Draft Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Data by Sex - Comments form

January 9, 2012

This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below.

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

In order to seek clarification between user's comments, we ask that you include your name, telephone number, full mailing or email address. If you chose to provide the personal information, it will not be shared with other parties and will not be used for any purpose other than the ones listed above. The personal information that you provide in this form is protected under the Privacy Act.

  • Comments submitted by: <full name>, <company/association name (if applicable)>
  • Telephone number: <telephone number>
  • Address: <full mailing or e-mail address>
  • Date: <date of comment submission>
  • Comment #
  • Section
  • Comment and Rationale
  • Proposed Revised Text